LIQID Medical Developing the world's first definitive cure for severe glaucoma

LIQID Medical

LIQID Medical

LIQID Medical is a double award-winning biotechnology start-up company focused on developing truly innovative and high impact ophthalmic devices. Our flagship device, the OptiShunt, is a patented ocular implant which offers the first hope of a definitive cure for glaucoma, the leading cause of irreversible blindness worldwide. Our core mission is to prevent global blindness, particularly in Africa. Our vision is to establish ourselves as a valuable and leading biotechnology company.

Stage Unknown EST April 2017
Sectors Biotechnology and medical research
Location Cape Town, South Africa
Markets South Africa
Contact Login to view details
Social media